Risperdal Victim Asks Pa. Judge For New Damages Trial
After winning a $500,000 verdict against a Johnson & Johnson unit last week when a Philadelphia jury found the antipsychotic drug Risperdal had hidden risks and caused a male patient to...To view the full article, register now.
Already a subscriber? Click here to view full article